Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597207 · ClinicalTrials.gov registry record · NA
Circulation Improving Resuscitation Care (CIRC)
A NA study, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 4,231
- Enrollment target
NCT00597207: Completed NA study, sponsored by Zoll Medical Corporation.
NCT00597207 is a NA study that has completed, run by Zoll Medical Corporation. The registered enrollment target is 4,231 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (201% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597207, a NA study, has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,231 participants
- Enrollment target
Study Summary
During resuscitation of out of hospital cardiac arrest patients the use of a mechanical chest compression device Autopulse will improve survival compared to manual compressions.
Primary Outcome
Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.
Interventions
- DEVICE AutoPulse
- OTHER Manual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,231 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT00597207 record still lists
NCT00597207 is an interventional study that assigns participants to a tested intervention. Its 4,231 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (201% higher).
The record links to 0 conditions, and to 2 interventions - of which AutoPulse is the first listed.
NCT00597207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00597207 about?
NCT00597207 is a clinical study titled "Circulation Improving Resuscitation Care (CIRC)". During resuscitation of out of hospital cardiac arrest patients the use of a mechanical chest compression device Autopulse will improve survival compared to manual compressions.
What is the current status of trial NCT00597207?
This trial is currently completed. It is a NA study. The enrollment target is 4,231 participants. The study started on 2008-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00597207?
The interventions under investigation include: AutoPulse (DEVICE), Manual (OTHER).
Who is sponsoring clinical trial NCT00597207?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00597207's enrollment target sits among peer trials
4,231 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06492616 · 4,220 participants · Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia